Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EBTC
4151
DELISTED
Enterprise Bancorp
EBTC
| $164K | ﹤0.01% |
6,890
+3,895
| +130% | +$90.4K |
|
4152
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.46B
| $164K | ﹤0.01% |
2,481
+99
| +4% | +$6.42K |
|
4153
Movado Group
MOV
$840M
| $164K | ﹤0.01% |
15,034
-1,294
| -8% | -$14K |
|
4154
Madison Square Garden
MSGS
$9.43B
| $164K | ﹤0.01% |
1,107
-12,313
| -92% | -$2.03M |
|
4155
CALL
Nektar Therapeutics
NKTR
$2.48B
| $164K | ﹤0.01% |
473
-3,620
| -88% | -$1.13M |
|
4156
PUT
Nutrien
NTR
$32B
| $164K | ﹤0.01% |
5,100
-18,500
| -78% | -$644K |
|
|
UNVR
4157
DELISTED
Univar Solutions Inc.
UNVR
| $164K | ﹤0.01% |
9,712
-952
| -9% | -$13.7K |
|
4158
Vitamin Cottage Natural Grocers
NGVC
$748M
| $163K | ﹤0.01% |
10,961
+4,771
| +77% | +$58.1K |
|
4159
NVE Corp
NVEC
$626M
| $163K | ﹤0.01% |
2,633
+1,047
| +66% | +$59.8K |
|
4160
Clean Energy Fuels
CLNE
$410M
| $162K | ﹤0.01% |
73,328
+28,486
| +64% | +$57.5K |
|
4161
Tempest Therapeutics
TPST
$14.4M
| $162K | ﹤0.01% |
472
+149
| +46% | +$59.4K |
|
4162
PUT
Western Union
WU
$2.23B
| $162K | ﹤0.01% |
7,500
-4,700
| -39% | -$95.4K |
|
4163
Artesian Resources
ARTNA
$355M
| $161K | ﹤0.01% |
4,433
+1,782
| +67% | +$62.6K |
|
|
CTRA
4164
CALL
DELISTED
Coterra Energy
CTRA
| $161K | ﹤0.01% |
9,400
-27,800
| -75% | -$539K |
|
4165
CALL
ScottsMiracle-Gro
SMG
$3.61B
| $161K | ﹤0.01% |
1,200
-1,300
| -52% | -$168K |
|
|
CALB
4166
DELISTED
California BanCorp Common Stock
CALB
| $161K | ﹤0.01% |
+10,741
| New | +$156K |
|
|
MFNC
4167
DELISTED
Mackinac Financial Corporation
MFNC
| $161K | ﹤0.01% |
15,519
+11,862
| +324% | +$117K |
|
4168
Coastal Financial
CCB
$671M
| $160K | ﹤0.01% |
11,033
+2,411
| +28% | +$31.8K |
|
4169
Hurco Companies Inc
HURC
$142M
| $160K | ﹤0.01% |
5,717
+2,236
| +64% | +$65.6K |
|
4170
CALL
Rambus
RMBS
$10.6B
| $160K | ﹤0.01% |
10,500
-31,800
| -75% | -$448K |
|
|
UBX
4171
DELISTED
Unity Biotechnology
UBX
| $160K | ﹤0.01% |
1,853
+902
| +95% | +$66.9K |
|
|
ENLC
4172
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $160K | ﹤0.01% |
65,557
-1,525,900
| -96% | -$3.15M |
|
4173
Energy Recovery
ERII
$450M
| $159K | ﹤0.01% |
20,855
+5,373
| +35% | +$42.6K |
|
4174
POSCO
PKX
$17B
| $159K | ﹤0.01% |
4,300
-18,000
| -81% | -$659K |
|
4175
ProShares UltraPro Short QQQ
SQQQ
$1.77B
| $159K | ﹤0.01% |
34
-292
| -90% | -$2.05M |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.